Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2013

Martz J, Jain S, Vahdat LT, Qin L, Mosquera JM, Antonescu CR, et al. High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors. J Clin Oncol. 2013;31(11):e181-5.

Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, et al. Gleason grade progression is uncommon. Cancer Res. 2013;73(16):5163-8.

Tabbo F, Ponzoni M, Rabadan R, Bertoni F, Inghirami G. Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma. Curr Opin Hematol. 2013;20(4):374-81.

Heymann JJ, Saqi A, Turk AT, Crapanzano J. Micropapillary urothelial carcinoma: Cytologic features in a retrospective series of urine specimens. Cytojournal. 2013;10:4.

Boiocchi L, Espinal-Witter R, Geyer JT, Steinhilber J, Bonzheim I, Knowles DM, et al. Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease. Mod Pathol. 2013;26(2):204-12.

Liao SY, Rodgers WH, Kauderer J, Darcy KM, Carter R, Susumu N, et al. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study. Br J Cancer. 2013;108(3):613-20.

Tewari A, Ludwig W, Takenaka A, Srivastava A, Chopra S, Pham A, et al. Reply from Authors re: Declan G. Murphy, Anthony J. Costello. How Can the Autonomic Nervous System Contribute to Urinary Continence Following Radical Prostatectomy? A "Boson-like" Conundrum. Eur Urol 2013;63:445-7: Sparing of the Neurovascular Bundle Lead. Eur Urol. 2013;63(3):447-9.

Tsui JF, Weinberger JM, Kashan M, Weiss JP, Robinson BD, Blaivas JG. Bladder lipoma. J Urol. 2013;190(4):1387-8.

Liu Z, Zanata SM, Kim J, Peterson MA, Di Vizio D, Chirieac LR, et al. The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation. Oncogene. 2013;32(13):1660-9.

Brady N, Chuntova P, Bade LK, Schwertfeger KL. The FGF/FGFR axis as a therapeutic target in breast cancer. Expert Rev Endocrinol Metab. 2013;8(4):391-402.